Keyword Index

C

  • Carnett´s sign Management of chronic abdominal wall pain: A one-year study [5.1, Issue 1, 2020, Pages 33-40]
  • Chronic hepatitis Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Coronavirus disease Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • COVID-19 Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Crohn’s disease and ulcerative colitis Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]

D

  • Direct-acting antiviral agents Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]

E

  • Endoscopy Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]

F

  • Fatty liver index Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]
  • FIB-4 score Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]

G

  • Gastrointestinal bleeding Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • GLP1-RAs Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]

H

  • HCV Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Hepatitis C genotyping HCV Genotype 5a presenting with hepatocellular cancer: First report from India [5.1, Issue 1, 2020, Pages 1-2]
  • Hepatitis C virus HCV Genotype 5a presenting with hepatocellular cancer: First report from India [5.1, Issue 1, 2020, Pages 1-2]
  • Hepatitis C virus Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Hepatocellular carc-inoma HCV Genotype 5a presenting with hepatocellular cancer: First report from India [5.1, Issue 1, 2020, Pages 1-2]
  • Human albumin Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]

N

  • NAFLD Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]

O

  • Occult HCV Infection Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]

S

  • SARS-CoV-2 Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • Spontaneous Bacterial Peritonitis Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]

U